Clobazam, a benzodiazepine primarily employed for the management of certain epileptic conditions, and increasingly, for anxiety situations, represents an important therapeutic possibility across the continent. This article aims to offer essential information specifically adapted for EU patients, addressing everything from its function of action and

While ketamine has shown potential as a treatment for severe depression, its availability fluctuates significantly across Australia. Currently, ketamine therapy is primarily offered in specialized clinics and hospitals, often with a focus on patients who haven't benefited from traditional antidepressant medications. The regulatory landscape persist